Back to search
Relapsing Forms of MS
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Relapsing Forms of MS trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Relapsing Forms of MS trials you may qualify forIn this prospective, open-label, single-arm, single-institution trial, the investigators will accomplish the following two aims: 1. study the safety and tolera…
In this study, researchers will learn more about the effects of diroximel fumarate (DRF), also known as VUMERITY®, when taken during pregnancy in people with mu…
The primary objectives of the study are to estimate the risk of major congenital malformations (MCMs) in infants born to women with multiple sclerosis (MS) who…
This study will evaluate whether ofatumumab is excreted at quantifiable levels and at which concentrations in breast milk of lactating women with RMS). The stud…
In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses. It is a 2-part study. In…